May 16, 2017
The New York Times Magazine
The Genetics of Pooched-Out Pooches
November 6, 2016
Boston Business Journal
First Patient on Rhythm’s Obesity Drug Shows Promise
October 27, 2016
Endpoints News
Allergan’s Executive Team Orchestrates a $200M Buyout to Beef up Gastroenterology Pipeline
September 23, 2016
Nature Reviews Endocrinology
Neuroendocrinology: New Hormone Treatment for Obesity Caused by POMC-Deficiency
September 19, 2016
FierceBiotech’s 2016 “Fierce 15”
Rhythm: Tackling Rare and Ultrarare Diseases
August 26, 2016
The Wall Street Journal
New Hope in the Search for a Treatment for Obesity
July 28, 2016
Xconomy
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope?
July 21, 2016
Fierce Biotech
Rhythm Plays Well in Stellar Rare Obesity Data
July 21, 2016
Endpoints News
Rhythm Eyes a Pivotal Test After Rolling Through PhII with Upbeat Results for Rare Obesity Cases
July 21, 2016
HealthDay
New Drug May Treat Rare Obesity Disorder Causing Constant Hunger
July 21, 2016
MedPage Today
Rare Hormone Deficiency Responds to Novel Drug
July 21, 2016
International Business Times
Rare Obesity Disorder May Be Treated With New Drug, Study Finds
July 20, 2016
Medscape
Setmelanotide Normalizes Satiety in Obese With Rare Gene Defect
January 7, 2016
Fierce Biotech
FDA Gets into Rhythm with a ‘Breakthrough’ Title for Orphan Obesity Drug
January 21, 2015
The New York Times Magazine
“Food Is a Death Sentence to These Kids”
January 14, 2014
The New York Times
Seeking Clues to Obesity in Rare Hunger Disorder
